Order results by:
Issue | Title | |
Vol 6, No 1 (2010) | COMBINED ANTIHYPERTENSIVE THERAPY: ACE INHIBITOR PLUS CALCIUM CHANNEL BLOCKER. NEW ADVANTAGES OF THE KNOWN COMBINATION | Abstract similar documents |
S. A. Boitsov, R. M. Linchak | ||
"... attention is paid to usage of ACE inhibitor and calcium antagonist combination. ..." | ||
Vol 9, No 2 (2013) | FIXED COMBINATION OF THE CALCIUM CHANNEL BLOCKER LERCANIDIPINE AND ANGIOTENSIN CONVERTING ENZYME INHIBITOR ENALAPRIL: POSSIBILITY OF USAGE | Abstract similar documents |
O. D. Ostroumova, I. I. Kopchenov | ||
"... converting enzyme (ACE) inhibitor and dihydropyridine calcium antagonist are considered. Data on the efficacy ..." | ||
Vol 3, No 2 (2007) | RESULTS OF OUTPATIENT PROGRAM ON EFFECTIVE THERAPY OF REFRACTORY ARTERIAL HYPERTENSION | Abstract similar documents |
M. M. Batyushin, I. V. Derevyankina, M. Z. Gasanov, O. V. Akopova, K. I. Babiyan, Y. N. Boychenko, N. V. Vasilchenko, T. A. Gabysyan, S. Ch. Gayboryan, I. S. Golovatenko, N. M. Demkova, D. O. Dmitriev, E. V. Kirtava, O. L. Kotyankova, G. V. Ludanova, S. A. Lyashenko, A. E. Malichina, O. I. Poroshenko, A. V. Svechnikova, I. Y. Sidorov, E. V. Solyannikova, I. D. Tascheyan, E. A. Heygetyan, S. E. Evruyan | ||
"... converting enzyme (ACE) inhibitor, thiazid diuretic (indapamide) and dihydropyridine calcium antagonist ..." | ||
Vol 6, No 5 (2010) | NEW APPROACHES OF THE HYPERTENSION TREATMENT: FROM CHOOSING THE BEST DRUG TO CHOOSE THE OPTIMUM DRUGS COMBINATION | Abstract similar documents |
O. D. Ostroumova, E. A. Smolyarchuk, I. V. Khvorostyanaya | ||
"... are presented. The advantages of ACE inhibitor+calcium channel blocker combination are shown in terms ..." | ||
Vol 3, No 2 (2007) | CALCIUM ANTAGONISTS IN CLINICAL PRACTICE: FOCUS ON METABOLIC AND VASCULAR EFFECTS | Abstract similar documents |
D. V. Nebieridze | ||
"... The efficacy of calcium antagonists widely used in cardiological practice is proved both ..." | ||
Vol 4, No 2 (2008) | FROM THE SHORT ACTING NIFEDIPINE TO AMLODIPINE AND FIXED COMBINATIONS. HIGHLIGHTS THE PROBLEM FROM THE CURRENT GUIDELINES POINT OF VIEW | Abstract similar documents |
L. I. Katelnitskaya, L. A. Haisheva | ||
"... Calcium antagonists (CA) therapy of patients with arterial hypertension is focused on the base ..." | ||
Vol 10, No 1 (2014) | TREATMENT OF PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC SYNDROME. THE ROLE OF THE COMBINATION DRUGS | Abstract similar documents |
A. M. Shilov, M. S. Dulaeva, A. O. Osia, A. S. Lishuta | ||
"... for the combination of an ACE inhibitor with a dihydropyridine calcium channel blocker are reviewed. Data from ..." | ||
Vol 2, No 4 (2006) | CALCIUM ANTAGONISTS IN THE TREATMENT OF ARTERIAL HYPERTENSION DURING PREGNANCY | Abstract similar documents |
R. I. Striuk | ||
"... should be used immediately. Dihydropyridine calcium antagonists (CA) is drugs of choice for HT treatment ..." | ||
Vol 15, No 1 (2019) | Atherosclerosis and Osteoporosis. Common Targets for the Effects of Cardiovascular and Anti-osteoporotic Drugs (Part I). The Effect of Cardiovascular Drugs on Bone Strength | Abstract similar documents |
I. A. Skripnikova, N. A. Alikhanova, M. A. Kolchinа, M. A. Myagkova, O. V. Kosmatova | ||
"... of cardiovascular drugs, such as statins, beta-blockers, ACE inhibitors, diuretics, calcium antagonists and nitrates ..." | ||
Vol 6, No 1 (2010) | AMLODIPINE IN TREATMENT OF PATIENTS WITH CORONARY ARTERY DISEASE: FOCUS ON ANTIATHEROSCLEROTIC PROPERTIES | Abstract similar documents |
Yu. M. Lopatin | ||
"... Author discusses antiatherosclerotic effects of dihydropyridine calcium channel blocker ..." | ||
Vol 13, No 3 (2017) | HYPERTENSION IN POSTMENOPAUSAL WOMEN: RATIONALE FOR THE USE OF CALCIUM CHANNEL BLOCKERS IN ANTIHYPERTENSIVE THERAPY | Abstract similar documents |
O. A. Kislyak, A. V. Starodubova, A. A. Kopelev | ||
"... of using the last generation of calcium channel blockers in this clinical situation with an emphasis ..." | ||
Vol 9, No 1 (2013) | LERCANIDIPINE, CALCIUM CHANNEL BLOCKER OF THE THIRD GENERATION: NEW POSSIBILITIES IN THE TREATMENT OF ARTERIAL HYPERTENSION | Abstract similar documents |
O. D. Ostroumova, M. L. Maksimov, I. I. Kopchenov | ||
"... Classification, modes of action and clinical effects of calcium channel blockers are presented ..." | ||
Vol 2, No 3 (2006) | APPLICATION OF CALCIUM ANTAGONISTS IN PREVENTION OF CARDIOVASCULAR COMPLICATIONS DURING CARDIAC SURGERY | Abstract similar documents |
S. V. Nedogoda | ||
"... Results of randomized clinical trials on the usage of calcium antagonists (CA) in order to prevent ..." | ||
Vol 5, No 3 (2009) | FREE-RADICAL OXIDATION ACTIVITY IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION WITHOUT Q WAVE TREATED WITH EPROSARTAN OR ENALAPRIL ADDITIONALLY TO THE BASIC THERAPY | Abstract similar documents |
O. G. Zaylobidinov, Yu. N. Ziyaev, N. K. Kamilova, A. S. Khalilov, B. F. Mukhamedova | ||
Vol 6, No 1 (2010) | ANGIOTENSIN II RECEPTOR ANTAGONISTS AND ACE INHIBITORS: OPTIMIZATION OF CHOICE FOR TREATMENT OF CARDIOVASCULAR DISEASES | Abstract similar documents |
E. M. Khurs, A. V. Poddubnaya | ||
"... Aim. To evaluate the cardioprotective effects of ACE inhibitor, ramipril and angiotensin II ..." | ||
Vol 2, No 1 (2006) | ANTIHYPERTENSIVE TREATMENT IN ELDERLY PATIENTS WITH DIHYDROPYRIDINE CALCIUM ANTAGONISTS | Abstract similar documents |
Y. A. Karpov, V. V. Buza | ||
"... . Advantages of dihydropyridine calcium antagonists (DPCA) for AH treatment in elderly patients are proved ..." | ||
Vol 7, No 3 (2011) | TREATMENT OPTIMIZATION IN PATIENTS WITH STABLE ANGINA PECTORIS: FOCUS ON VERAPAMIL SR | Abstract similar documents |
I. M. Sokolov | ||
"... medications that slow down HR: beta blockers (BB), If-channel inhibitors, nondihydropyridine calcium channel ..." | ||
Vol 7, No 3 (2011) | DIHYDROPYRIDINE CALCIUM ANTAGONISTS. POSITION OF NIFEDIPINE IN MODERN CARDIOLOGY PRACTICE | Abstract similar documents |
A. A. Garganeeva | ||
Vol 6, No 4 (2010) | POSITIONS OF CALCIUM CHANNEL BLOCKER LERCANIDIPINE ACCORDING TO EVIDENCE BASED CARDIOLOGY | Abstract similar documents |
Yu. V. Lukina, S. Yu. Martsevich | ||
"... and safety of the modern calcium channel blocker (CCB), lercanidipine, are presented. Results of these trials ..." | ||
Vol 4, No 2 (2008) | DIHYDROPYRIDINE CALCIUM ANTAGONISTS: THE ROLE IN CURRENT THERAPY OF CARDIO-VASCULAR DISEASES | Abstract similar documents |
E. V. Shilova, S. Y. Martsevich | ||
"... Classification of calcium antagonists (CA) is presented. Results of the large clinical trials ..." | ||
Vol 4, No 5 (2008) | ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: ADVANTAGES OF CALCIUM ANTAGONISTS | Abstract similar documents |
T. V. Adasheva, I. V. Fedorova, V. S. Zadionchenko, M. V. Macievich, V. V. Lee, S. V. Pavlov | ||
Vol 6, No 3 (2010) | EFFECTS OF CALCIUM ANTAGONISTS OF THE THIRD GENERATION IN PATIENTS WITH ARTERIAL HYPERTENSION AND CONCOMITANT CHRONIC OBSTRUCTIVE PULMONARY DISEASE | Abstract similar documents |
D. A. Yakhontov, N. F. Balabanova | ||
"... of the second group received any other antihypertensive therapy except dihydropyridine calcium antagonists ..." | ||
Vol 10, No 4 (2014) | TREATMENT OF HYPERTENSION IN PREGNANCY: GUIDELINES AND CLINICAL EXPERIENCE | Abstract similar documents |
O. V. Gaisenok, O. A. Zamyatina, N. Yu. Denisova, A. S. Leonov | ||
Vol 16, No 1 (2020) | High Blood Pressure Variability is an Additional Cardiovascular Risk Factor | Abstract similar documents |
A. V. Rodionov | ||
"... , calcium antagonists, mainly amlodipine, have the greatest potential for the variability reduction ..." | ||
Vol 5, No 4 (2009) | TO THE 110-TH ANNIVERSARY OF RENIN FINDING. FIGHT OF TITANS: ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND SARTANS | Abstract similar documents |
L. N. Malay, A. N. Miroshnichenko, B. V. Sharykin, V. V. Konurovsky | ||
"... Angiotensin converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARB) slow ..." | ||
Vol 9, No 1 (2013) | THE EFFICACY AND SAFETY OF DIHYDROPYRIDINE CALCIUM CHANNEL BLOCKERS IN HYPERTENSIVE PATIENTS: AMLODIPINE PLACE | Abstract similar documents |
M. V. Lebedeva, V. D. Beketov, N. V. Maltsev, M. E. Safarova | ||
Vol 11, No 5 (2015) | A modern choice for patients with hypertension: the possibility of new calcium antagonist of III generation | Abstract similar documents |
E. I. Emelina, G. E. Gendlin | ||
"... Features and possibility of application of the calcium channel blocker lercanidipine in cardiology ..." | ||
Vol 3, No 5 (2007) | CLINICAL AND PHARMACOKINETIC EQUIVALENCE OF ORIGINAL AND GENERIC AMLODIPINE IN PATIENTS WITH MILD-TO-MODERATE ARTERIAL HYPERTENSION | Abstract similar documents |
N. A. Belolipetskiy, S. N. Tolpygina, J. B. Zverkov, V. V. Pisarev, I. E. Koltunov, V. G. Belolipetskaya, S. J. Martsevich | ||
Vol 3, No 1 (2007) | DIHYDROPYRIDINE CALCIUM ANTAGONISTS: DATA OF EVIDENCE BASED MEDICINE AND RECOM-MENDATIONS ON PRACTICAL USE | Abstract similar documents |
S. Y. Martsevich | ||
"... The classification of calcium antagonists is presented. There were considered the results of large ..." | ||
Vol 6, No 1 (2010) | SOME ASPECTS OF THE LISINOPRIL USAGE IN ARTERIAL HYPERTENSION TREATMENT | Abstract similar documents |
N. A. Jaiani | ||
"... Рассматриваются обоснования и преимущества применения ингибитора АПФ лизиноприла в практической ..." | ||
Vol 8, No 1 (2012) | BETA-BLOCKERS IN THE TREATMENT OF ARTERIAL HYPERTENSION: EVIDENCE BASED DATA AND REAL PRACTICE | Abstract similar documents |
M. V. Leonova | ||
"... . The role of beta-blockers among other basic groups of antihypertensive drugs (thiazide diuretics, calcium ..." | ||
Vol 9, No 3 (2013) | THE ROLE OF S-AMLODIPINE IN ARTERIAL HYPERTENSION THERAPY WITH COMBINATION OF CALCIUM CHANNEL BLOCKERS AND BETA-BLOCKERS | Abstract similar documents |
M. A. Maksimova, Yu. V. Lukina, S. Yu. Martsevich | ||
"... Aim. To study efficacy and safety of calcium channel blocker, S-amlodipine, in combination with β ..." | ||
Vol 10, No 5 (2014) | CHOICE OF LISINOPRIL FOR TREATMENT OF HYPERTENSION IN PATIENTS WITH CONCOMITANT DISEASES | Abstract similar documents |
N. A. Dzhaiani | ||
"... Rationale and benefits of the use of the ACE inhibitor lisinopril in the clinical practice ..." | ||
Vol 5, No 1 (2009) | ACE INHIBITORS IN ARTERIAL HYPERTENSION TREATMENT: FOCUS ON LISINOPRIL | Abstract similar documents |
V. I. Podzolkov, K. K. Osadchy | ||
"... Approaches to the choice of antihypertensive pharmacotherapy are discussed. Evidence base of ACE ..." | ||
Vol 10, No 2 (2014) | ADVANTAGES OF COMBINATION THERAPY OF HYPERTENSION WITH CALCIUM CHANNEL BLOCKER AND ANGIOTENSIN-CONVERTING ENZYME INHIBITOR IN PATIENTS WITH IMPAIRED RENAL FUNCTION | Abstract similar documents |
N. A. Dzhaiani | ||
"... disease are presented. Special attention is paid to the fixed combination of calcium antagonist ..." | ||
Vol 6, No 4 (2010) | COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION AFTER THE STROKE | Abstract similar documents |
O. A. Ageenkova, V. A. Milyagin, N. Yu. Hozyainova | ||
"... . Calcium channel blocker amlodipine (5 mg QD) was added in case of insufficient effect of the ACE inhibitor ..." | ||
Vol 4, No 2 (2008) | ACE INHIBITORS ARE RATIONAL PHARMACOTHERAPY OF ENDOTHELIAL DYSFUNCTION | Abstract similar documents |
M. P. Metrova, A. B. Salmina, A. I. Inzhutova, O. S. Bahmeteva | ||
"... Aim. To study effects of ACE inhibitor perindopril on markers of endothelial dysfunction ..." | ||
Vol 14, No 2 (2018) | FIVE-YEAR DYNAMICS OF SECONDARY PREVENTION IN PATIENTS WITH STABLE ANGINA AT SPECIALIZED OUT-PATIENT LEVEL IN MOSCOW (PHARMACOEPIDEMIOLOGY STUDY) | Abstract similar documents |
S. В. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, K. O. Tsukanova | ||
"... .3%, statins – up to 45.6%. Despite of no changes registered in prescription rate of the ACE inhibitors, marked ..." | ||
Vol 5, No 3 (2009) | ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN MANAGEMENT OF PATIENTS WITH CHRONIC HEART FAILURE | Abstract similar documents |
S. N. Tereshchenko, N. A. Dzhaiani | ||
"... The role of ACE inhibitors in modern pharmacotherapy of patients with chronic heart failure (CHF ..." | ||
Vol 8, No 4 (2012) | EFFECT OF CARDIOVASCULAR DRUGS ON BONE HEALTH AND THE POSSIBILITY OF THEIR USE FOR THE PREVENTION OF OSTEOPOROSIS | Abstract similar documents |
I. A. Skripnikova, K. E. Sobchenko, O, V. Kosmatova, D. V. Nebieridze | ||
"... and, first of all beta-blockers, ACE inhibitors, diuretics, and statins on bone are presented. Mode of action ..." | ||
Vol 4, No 3 (2008) | COMPARATIVE EFFICACY OF ACE INHIBITORS (RAMIPRIL VS ENALAPRIL) IN TREATMENT OF CHRONIC HEART FAILURE IN WOMEN | Abstract similar documents |
S. N. Tereshchenko, I. V. Zhirov, E. V. Malichenko, E. E. Kazantseva | ||
Vol 4, No 3 (2008) | ANGIOTENSIN II AND MYOCARDIAL INFARCTION | Abstract similar documents |
O. P. Shevchenko, А. О. Shevchenko | ||
"... -thrombosis action, promotes MI expansion and post-MI remodeling. Angiotensin converting enzyme (ACE ..." | ||
Vol 11, No 3 (2015) | THE NEW FIXED COMBINATION OF AMLODIPINE AND RAMIPRIL IN THE TREATMENT OF HYPERTENSION | Abstract similar documents |
V. I. Podzolkov, A. I. Tarzimanova | ||
"... pathogenic mechanisms of hypertension. The combination of an ACE inhibitor and a dihydropyridine calcium ..." | ||
Vol 7, No 4 (2011) | COMBINATION OF DIRECT RENNIN INHIBITOR - ALISKIREN, ANGIOTENSIN II RECEPTOR BLOCKER - VALSARTAN, AND CALCIUM CHANNEL BLOCKER - AMLODIPINE, IN THERAPY OF HYPERTENSIVE PATIENT WITH GOUT (CASE REPORT) | Abstract similar documents |
O. V. Dralova, M. L. Maksimov | ||
Vol 1, No 1 (2005) | ACE INHIBITORS IN PATIENTS WITH ISCHEMIC HEART DISEASE WITHOUT HEART FAILURE: CLASS EFFECTS AND EFFICACY OF ITS REPRESENTATIVES | Abstract similar documents |
Y. A. Karpov | ||
"... of the role of ACE inhibitors in treatment of patients with stable form of ischemic heart disease without ..." | ||
Vol 9, No 4 (2013) | ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS: IS THERE A REASON TO CONSIDER AN EQUIVALENCE OF TWO DRUG CLASSES FROM THE EVIDENCE BASED MEDICINE STANDPOINT | Abstract similar documents |
S. Yu. Martsevich | ||
"... The results of the main large controlled trials that had proven effect of ACE inhibitors (ACEi ..." | ||
Vol 6, No 4 (2010) | ACE INHIBITOR POSSIBILITIES IN CLINICAL PRACTICE: WHAT WE KNOW ABOUT THEM? | Abstract similar documents |
D. V. Nebieridze, A. S. Safarian | ||
"... New possibilities of ACE inhibitors application on the base of international trails review ..." | ||
Vol 13, No 2 (2017) | SECONDARY PREVENTION IN PATIENTS AFTER MYOCARDIAL INFARCTION AT AMBULATORY SPECIALIZED CARDIOLOGY INSTITUTION (PHARMACOEPIDEMIOLOGY STUDY) | Abstract similar documents |
S. B. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, D. A. Dimitrova | ||
Vol 11, No 2 (2015) | THE EFFECTIVENESS OF LERCANIDIPINE IN REDUCING THE RISK OF ARTERIAL HYPERTENSION COMPLICATIONS | Abstract similar documents |
E. EL. Trisvetova | ||
"... pressure (BP) levels remains inadequate. Dihydropyridine calcium channel blockers show antihypertensive ..." | ||
Vol 6, No 6 (2010) | NEW POSSIBILITIES OF STATIN THERAPY IN ARTERIAL HYPERTENSION | Abstract similar documents |
E. M. Khurs, A. V. Poddubnaya, M. G. Evsina, E. M. Futerman, O. G. Smolenskaya | ||
"... .23. Patients were randomized into 4 treatment groups: Group A1 (angiotensin converting enzyme (ACE) inhibitors ..." | ||
Vol 14, No 6 (2018) | Availability and Affordability of Medicines for the Treatment of Cardiovascular Diseases in Pharmacies in Six Regions of the Russian Federation | Abstract PDF (Eng) similar documents |
A. E. Imaeva, Yu. A. Balanova, A. V. Kontsevaya, A. V. Kapustina, D. V. Duplyakov, O. H. Malysheva, I. V. Osipova, T. A. Petrichko, G. I. Kropanin, R. A. Kasimov, D. A. Leon, M. McKee | ||
"... lower than ACE inhibitors. Bisoprolol was most common beta-blocker. Calcium antagonists: if amlodipine ..." | ||
Vol 1, No 1 (2005) | ARTERIAL HYPERTENSION IN RUSSIA: PROLOG STUDY AS A PROOF METHOD OF CONTEMPORARY THERAPY OPPORTUNITIES | Abstract similar documents |
S. A. Shalnova, S. Y. Martsevich, A. D. Deev, N. P. Kutishenko, P. G. Oganov, A. N. Britov, E. G. Volkova, K. I. Ivanov, A. M. Kalinina, L. I. Katelnitskaya, G. D. Kobalava, E. V. Kokurina, A. O. Conradi, S. K. Kukushkin, Yu. M. Lopatin, N. I. Maksimov, V. Y. Mareev, I. S. Petelin, D. V. Nebieridze, G. I. Nechayev, L. A. Sokolova, A. V. Suslikov, I. G. Fomina, A. V. Shabalin, V. A. Shulman, V. V. Yakusevich, S. S. Jakushin | ||
"... antihypertensive therapy based on ACE-inhibitor spirapril, the second one (control group) continued their usual ..." | ||
Vol 6, No 2 (2010) | RATIONAL COMBINATIONS IN HYPERTENSION TREATMENT | Abstract similar documents |
V. I. Podzolkov, A. I. Tarzimanova | ||
"... Influence of the combined antihypertensive therapy, including combination of emACE/em inhibitors ..." | ||
Vol 2, No 4 (2006) | POSTMENOPAUSAL METABOLIC SYNDROME: CORRECTION OF AUTONOMIC NERVOUS SYSTEM DISBALANCE WITH COMBINATION OF ACE-INHIBITOR AND STATIN | Abstract similar documents |
I. V. Logacheva, E. N. Shustova, E. V. Kulinich | ||
"... (emACE/em inhibitor and statin), not only have antihypertensive and hypolipidemic action, but also reduce ..." | ||
Vol 5, No 2 (2009) | CARDIOPROTECTIVE AND NEPHROPROTECTIVE EFFECTS OF ANGIOTENSIN CONVERTING ENZYME INHIBITOR RAMIPRIL | Abstract similar documents |
D. A. Napalkov, E. N. Golovenko | ||
"... There is grate interest to emACE/em inhibitors which have cardioprotective and neproprotective effects ..." | ||
Vol 9, No 5 (2013) | TREATMENT OF PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE IN REAL CLINICAL PRACTICE ACCORDING TO THE DATA FROM PROGNOZ IBS REGISTER (PART 2) | Abstract similar documents |
S. N. Tolpygina, Yu. N. Polyanskaya, S. Yu. Martsevich | ||
"... - by 70%, emACE/em inhibitors - by 60% (p0.0001). These medications prescription frequency decreased by 15-20 ..." | ||
Vol 4, No 4 (2008) | PLACE OF ANGIOTENSIN II RECEPTOR ANTAGONISTS IN ARTERIAL HYPERTENSION THERAPY | Abstract similar documents |
S. A. Boytsov, I. P. Kolos | ||
Vol 4, No 1 (2008) | COMPARISON OF ACE INHIBITOR (FOSINOPRIL) AND Β-ADRENOBLOCKER (ATENOLOL) EFFECTS ON AUTONOMIC REGULATION OF THE HEART IN PATIENTS WITH ARTERIAL HYPERTENSION | Abstract similar documents |
A. R. Kiselyov, V. I. Gridnev, O. V. Shevchenko, O. M. Posnenkova, A. N. Strunina, V. A. Schwarz, Ja. P. Dovgalevsky | ||
Vol 5, No 6 (2009) | EXPERIENCE OF RAMIPRIL (HARTIL) USAGE IN PATIENTS WITH HIGH CARDIOVASCULAR RISK (THE OPTIMIST STUDY) | Abstract similar documents |
I. A. Velizhanina, L. I. Gapon, E. S. Velizhanina, M. I. Shupina, A. V. Rudakov, T. S. Bondarenko | ||
"... ,4%) patients received emACE/em inhibitors, 435 (55%) patients - beta-blockers, 230 (29,1%) patients - emcalcium/em ..." | ||
Vol 2, No 2 (2006) | PECULIARITIES OF ARTERIAL HYPERTENSION DIAGNOSIS AND SECONDARY PREVENTION ACCORDING TO PHYSICIANS INTERVIEWING | Abstract similar documents |
N. S. Oganisyan, N. A. Dmitrieva, A. M. Kochetkov, S. Y. Martsevich | ||
"... therapy was presented by four classes of medicines, their shares were as follow: emACE/em inhibitors - 35 ..." | ||
Vol 1, No 3 (2005) | COMPARATIVE ASSESSMENT OF EFFECT OF COMBINED DRUGS OF ACE INHIBITOR AND DIURETIC (“NOLIPREL FORTE” AND “CAPOZIDE”) ON CARDIOVASCULAR REMODELING IN HYPERTENSIVE PATIENTS | Abstract similar documents |
T. D. Kaplanov, V. V. Ivanenko, N. V. Ryasancevа, A. V. Legkiy, L. P. Anisimova, Yu. M. Lopatin | ||
"... drugs of emACE/em inhibitor and diuretic, “Noliprel forte” (NF) and “Capozide” (CA), in hypertensive high ..." | ||
Vol 9, No 2 (2013) | PLEIOTROPIC EFFECTS OF PARATHYROIDECTOMY AND AGONIST CALCIUM-SENSITIVE RECEPTOR, CINACALCET | Abstract similar documents |
L. V. Egshatyan, L. Ya. Rozhinskaya, N. S. Kuznetsov, M. Sh. Shamkhalova | ||
"... levels of albumin, total emcalcium/em, phosphorus, total cholesterol (TC), low (LDL) and high density ..." | ||
Vol 9, No 1 (2013) | MYOCARDIAL FIBROSIS IN PATIENTS WITH DIABETES MELLITUS | Abstract similar documents |
O. M. Drapkina, B. B. Gegenava | ||
Vol 7, No 3 (2011) | EFFICACY AND TOLERABILITY OF LERCANIDIPINE IN ELDERLY PATIENTS WITH MILD TO MODERATE HYPERTENSION IN A PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY | similar documents |
M. A. Ninci, R. Magliocca, A. Malliani | ||
"... Цель. Оценить эффективность лерканидипина (emантагониста/em emкальция/em из группы дигидропиридинов) у ..." | ||
Vol 15, No 2 (2019) | Modern Recommendations and Real Clinical Practice: the Results of the SILA Study | Abstract similar documents |
O. A. Kislyak, I. I. Chukaeva, V. A. Vygodin | ||
"... (in different regions). Patients received emACE/em inhibitors in 50-54% of cases, angiotensin receptor blockers ..." | ||
Vol 4, No 1 (2008) | WHAT CAN WE EXPECT USING ACE INHIBITOR RAMIPRIL IN PERSONS WITH HIGH CARDIOVASCULAR RISK AND EARLY DISORDERS OF CARBOHYDRATE METABOLISM? LESSONS OF DREAM TRIAL | Abstract similar documents |
M. N. Mamedov, M. B. Stroeva | ||
"... . Results of DREAM trial are discussed. Influence of emACE/em inhibitor, ramipril, on risk of diabetes onset ..." | ||
Vol 15, No 4 (2019) | Antihypertensive Drug Utilization in Two Districts of Northern Cyprus | Abstract PDF (Eng) similar documents |
M. Tamirci, R. Demirdamar | ||
"... .1%), angiotensin receptor blockers (ARBs) (22.1%), emcalcium/em channel blockers (20.4%), angiotensin converting enzyme ..." | ||
Vol 6, No 5 (2010) | THE USE OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS AFTER MYOCARDIAL INFARCTION. WHAT DO EVIDENCE-BASED MEDICINE DATA SPEAK FOR? | Abstract similar documents |
S. Yu. Martsevich | ||
"... The main trails proven angiotensin converting enzyme (emACE/em) inhibitor effects on the life prognosis ..." | ||
Vol 16, No 2 (2020) | Treatment of Patients with COVID-19 and Concomitant Cardiovascular Diseases: Do not Forget About the Principles of Evidence-based Medicine | Abstract similar documents |
S. Yu. Martsevich | ||
"... The recent discussion about the dangers of using angiotensin-converting-enzyme (emACE/em) inhibitors ..." | ||
Vol 4, No 1 (2008) | EDITORIAL COMMENTS ON THE ARTICLE OF M.N. MAMEDOV AND M.V. STROEVA “WHAT CAN WE EXPECT USING ACE INHIBITOR RAMIPRIL IN PERSONS WITH HIGH CARDIOVASCULAR RISK AND EARLY DISORDERS OF CARBOHYDRATE METABOLISM? LESSONS OF DREAM TRIAL” | Abstract similar documents |
статья Редакционная | ||
Vol 3, No 1 (2007) | THE CAPABILITIES OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN CLINICAL PRACTICE: FOCUS ON VASOPROTECTION | Abstract similar documents |
D. B. Nebieridze, A. S. Safaryan | ||
"... enzyme (emACE/em) inhibitors in clinical practice were represented. The traditional usage of emACE/em inhibitors ..." | ||
Vol 9, No 2 (2013) | ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS: ISN'T IT TIME TO DRAW A LINE UNDER DISCUSSION ABOUT SUPERIORITY | Abstract similar documents |
S. Yu. Martsevich | ||
"... ингибиторов emАПФ/em и блокаторов рецепторов ангиотензина у больных без сердечной недостаточности (перевод ..." | ||
Vol 4, No 1 (2008) | EFFECT OF ANGIOTENSIN-II RECEPTOR ANTAGONIST LOSARTAN AND ITS COMBINATION WITH DIURETICS ON MYOCARDIAL MORPHO-FUNCTIONAL CONDITIONS IN HYPERTENSIVE PATIENTS WITH LEFT VENTRICULAR HYPERTROPHY | Abstract similar documents |
S. N. Tolpygina, E. V. Oschepkova, L. M. Sergakova, A. N. Rogoza | ||
Vol 17, No 3 (2021) | Ability of Evaluation Coronary Calcium Index Based on Ultra-Low-Dose Computed Tomography Used in Moscow Lung Cancer Screening Project | Abstract similar documents |
A. E. Nikolaev, A. N. Shapiev, O. A. Korkunova, G. Z. Mukhutdinova, P. V. Tkacheva, M. M. Suleymanova, A. N. Shapieva, D. M. Ramazanova, M. N. Rzayev, V. A. Gombolevsky | ||
"... Aim. Determination of the possibility of reliable quantitative assessment of the coronary emcalcium/em ..." | ||
Vol 20, No 5 (2024) | Association between renin-angiotensin system gene polymorphism and cardio-ankle vascular index in patients with COVID-19 | Abstract similar documents |
V. I. Podzolkov, A. E. Bragina, E. S. Ogibenina, I. I. Shvedov, A. R. Komelkova | ||
"... -converting enzyme type 1 gene (emACE/em1), rs5186 of angiotensin II type 1 receptor gene (ATP1), and rs1403543 ..." | ||
Vol 7, No 1 (2011) | SUPPRESSION OF RENIN-ANGIOTENSIN SYSTEM TO PREVENT COMPLICATIONS OF CARDIOVASCULAR DISEASES: CURRENT "ROLES" DISTRIBUTION FROM CLINICAL PHARMACOLOGIST’S POINT OF VIEW | Abstract similar documents |
S. R. Gilyarevskiy, V. A. Orlov, M. V. Golshmid, G. Yu. Zakharova, I. I. Sinitsina | ||
"... A role of angiotensin-converting enzyme (emACE/em) inhibitors in cardiovascular diseases treatment ..." | ||
Vol 14, No 1 (2018) | COMPARATIVE ANALYSIS OF HOSPITAL PHARMACOTHERAPY OF CHRONIC HEART FAILURE WITH REDUCED LEFT VENTRICULAR EJECTION FRACTIONS IN 2009-2010 AND 2014-2015 | Abstract similar documents |
O. V. Reshetko, A. V. Sokolov, E. V. Rykalina, N. V. Furman | ||
"... .05) increased. In 2014-2015 the frequency of the prescriptions of emACE/em inhibitors decreased (77.8 vs 86.5%; p0 ..." | ||
Vol 7, No 5 (2011) | СHOICE OF ZOFENOPRIL AND HYDROCHLOROTHIAZIDE COMBINATION IN THE TREATMENT OF ARTERIAL HYPERTENSION | Abstract similar documents |
N. A. Dzhaiani | ||
"... situation with arterial hypertension. emACE/em inhibitors have a special place among the antihypertensive drugs ..." | ||
Vol 3, No 3 (2007) | ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN ACUTE MYOCARDIAL INFARCTION: WHEN TO START THERAPY AND WHICH DRUG TO USE? | Abstract similar documents |
S. Y. Martsevich, S. N. Tolpygina | ||
"... Data of studies devoted to application of angiotensin converting enzyme (emACE/em) inhibitors in acute ..." | ||
Vol 2, No 1 (2006) | ARE ALL THE PROLONGED DRUG FORMULATIONS OF NIFEDIPINE THE SAME? | Abstract similar documents |
V. G. Kukes, D. A. Sychev | ||
"... Publication is devoted to the emcalcium/em antagonist nifedipine in drug formulations of the prolonged ..." | ||
Vol 12, No 1 (2016) | The main factors affecting the long-term outcomes in patients after acute cerebrovascular disorder: results of the LIS-2 study | Abstract similar documents |
S. Yu. Martsevich, N. P. Kutishenko, A. V. Suvorov, A. V. Zagrebelnyy, M. L. Ginzburg, A. D. Deev | ||
"... (RR=1.6), atrial fibrillation (RR=1.4). Patients who were treated with emcalcium/em channel blockers before ..." | ||
Vol 8, No 1 (2012) | EFFICACY OF FIXED COMBINATION OF VALSARTAN, AMLODIPINE AND HYDROCHLOROTHIAZIDE IN COMPLEX THERAPY OF THE PATIENT OF VERY HIGH CARDIOVASCULAR RISK | Abstract similar documents |
I. M. Sokolov, N. A. Zheleznyakova | ||
"... clinical trials. The triple combination of emcalcium/em antagonist, angiotensin II receptor blocker and thiazide ..." | ||
Vol 14, No 6 (2018) | Effectiveness of Chrono-Pharmacotherapy Depending on the Salt Sensitivity of Patients with Arterial Hypertension and Diabetes Mellitus Type 2 | Abstract PDF (Eng) similar documents |
V. V. Skibitskiy, A. A. Kiselev, A. V. Fendrikova | ||
"... of the combination of thiazide-like diuretic with emcalcium/em channel blocker in the morning and emACE/em inhibitor in bedtime ..." | ||
Vol 15, No 2 (2019) | Pharmacoepidemiological Research of the Efficacy of Fixed Dose Combinations in the Treatment of Patients with Arterial Hypertension in Ambulatory Practice | Abstract similar documents |
E. V. Yakukhnaya, E. V. Solyanik, V. V. Khitrina, Yu. V. Kuznetsova | ||
"... containing emACE/em inhibitor (perindopril), emcalcium/em channel blocker (amlodipine) and thiazide-like diuretic ..." | ||
Vol 12, No 3 (2016) | GENETIC PREDICTORS OF ATRIAL FIBRILLATION | Abstract PDF (Eng) similar documents |
A. V. Kuskaeva, S. Yu. Nikulina, A. A. Chernova, N. V. Aksyutina | ||
"... ассоциативный эффект ингибиторов ангиотен- зинпревращающего фермента и emантагонистов/em рецепторов ангиотензина II в ..." | ||
Vol 9, No 4 (2013) | NORVASC® IN RUSSIA 20 YEARS LATER: CONTINUATION OF THE HISTORY | Abstract similar documents |
A. V. Rudenko, B. A. Rudenko | ||
"... Amlodipine combines the most important clinical effects of emcalcium/em antagonists with minimal side ..." | ||
Vol 7, No 2 (2011) | CONTEMPORARY SIGHT AT AMLODIPINE AND NEW DRUGS OF S-AMLODIPINE | Abstract similar documents |
M. V. Leonova | ||
"... Contemporary scientific data about mode of action of emcalcium/em channel blocker — amlodipine, its ..." | ||
Vol 15, No 4 (2019) | Prevalence, Awareness, Treatment and Control of Hypertension in Russian Federation (Data of Observational ESSERF-2 Study) | Abstract PDF (Eng) similar documents |
Yu. A. Balanova, S. A. Shalnova, A. E. Imaeva, А. V. Kapustina, G. A. Muromtseva, S. V. Evstifeeva, V. I. Tarasov, A. N. Redko, I. A. Viktorova, N. N. Prishchepa, S. S. Yakushin, S. A. Boytsov, O. M. Drapkina | ||
"... .5%, diuretics – 22.7%, emcalcium/em antagonists – 15.7%, centrally acting drugs – 3.3%, others – 0.2%. The lack ..." | ||
Vol 12, No 6 (2016) | CHRONIC HEART FAILURE: CLINICAL GUIDELINES AND REAL CLINICAL PRACTICE | Abstract similar documents |
E. K. Shavarova, L. A. Babaeva, S. S. Padaryan, N. N. Soseliya, O. I. Lukina, A. S. Milto | ||
"... not receive medical treatment before admission. 34% of patients with HFrEF received emACE/em inhibitors/angiotensin ..." | ||
Vol 2, No 4 (2006) | FROM HOPE TRIAL TO ONTARGET TRIAL: THE «HOPE» TO REACH THE «TARGET» - TO IMPROVE PROGNOSIS IN HIGH RISK PATIENTS | Abstract similar documents |
Yu. M. Lopatin | ||
"... . The objectives and study design of ONTARGET/TRANSCEND trials are introduced. Perspectives of joint use of emACE/em ..." | ||
Vol 9, No 2 (2013) | TREATMENT OF PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE IN REAL CLINICAL PRACTICE ACCORDING TO THE DATA FROM PROGNOZ IBS REGISTER. (Part 1) | Abstract similar documents |
S. N. Tolpygina, Yu. N. Polyanskaya, S. Yu. Martsevich | ||
"... of cardiovascular complications (antiplatelets, β-blockers, emACE/em inhibitors, statins) were not often prescribed ..." | ||
Vol 3, No 3 (2007) | REDUCTION OF CUMULATIVE CARDIOVASCULAR RISK IN PATIENTS WITH ARTERIAL HYPERTENSION: THE ROLE OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS ACCORDING TO THE NEW EUROPEAN RECOMMENDATIONS | Abstract similar documents |
M. N. Mamedov, N. A. Chepurina, Z. N. Tokareva, A. A. Evdokimova | ||
"... of antihypertensive drugs in mono- and combined therapy. Angiotensin converting enzyme (emACE/em) inhibitors keep important ..." | ||
Vol 2, No 4 (2006) | ANGIOTENSIN CONVERTING ENZYME INHIBITORS: DECREASE IN HEART REMODELING AND IMPROVEMENT IN FUNCTION OF ENDOTHELIUM IN PATIENTS WITH ARTERIAL HYPERTENSION | Abstract similar documents |
K. Yu. Nikolaev, G. I. Lifshits, A. A. Nikolaeva, I. M. Gicheva | ||
"... Aim. To estimate an effect of enalapril, angiotensin converting enzyme (emACE/em) inhibitor , on left ..." | ||
Vol 4, No 5 (2008) | EFFECTS OF BETAHISTINE DIHYDROCHLORIDE AS ADJUVANT TO ENALAPRIL THERAPY OF PATIENTS WITH CHRONIC HEART FAILURE CLASS II-II (NYHA) SUFFERING FROM GIDDINESS | Abstract similar documents |
S. Y. Martsevich, J. V. Lukina, V. V. Yakusevich, D. A. Anichkov, A. D. Deev, O. V. Lerman, S. N. Tolpygina, N. A. Dmitrieva, A. A. Serazhim, M. A. Maksimova, V. P. Voronina, E. V. Shilova, G. F. Andreeva, A. V. Zaharova, I. V. Novikov, А. А. Platonova, Т. А. Kazakovtseva, T. V. Babkova, L. P. Volhonskaya | ||
"... Aim. To study adjuvant effect of betahistine dihydrochloride to emACE/em inhibitors in patients ..." | ||
Vol 5, No 3 (2009) | ARTERIAL HYPERTENSION IN PATIENTS WITH RHEUMATOID ARTHRITIS | Abstract similar documents |
N. M. Nikitina, A. P. Rebrov | ||
"... into account wide usage of non steroid antiinflammatory drugs emcalcium/em antagonists or angiotensin II receptor ..." | ||
Vol 4, No 5 (2008) | AMLODIPINE ADVANTAGES IN ARTERIAL HYPERTENSION THERAPY | Abstract similar documents |
V. M. Tsareva, N. J. Hozjainova, M. S. Bezaltynnyh, T. V. Brook, N. A. Borohova, I. E. Koltunov, N. M. Ahmedzhanov | ||
"... Aim. To study effects of emcalcium/em channel blocker, amlodipine on indices of ambulatory blood ..." | ||
Vol 6, No 5 (2010) | FIXED LOW-DOSE COMBINATION OF LISINOPRIL AND HYDROCHLOROTHIAZIDE IN THE PREVENTION OF CARDIOVASCULAR EVENTS IN HYPERTENSIVE PATIENTS | Abstract similar documents |
A. O. Shevchenko, O. P. Shevchenko | ||
"... and hydrochlorothiazide are discussed. Reasonability of emACE/em inhibitor and thiazide diuretic combination is supported due ..." | ||
Vol 14, No 3 (2018) | COMPARATIVE PHARMACOEPIDEMIOLOGICAL ASSESSMENT OF ANTIHYPERTENSIVE DRUGS PRESCRIPTION IN OUTPATIENT PRACTICE IN KURSK AND CHISINAU | Abstract similar documents |
S. V. Povetkin, O. V. Levashova, V. I. Ghicavii, N. G. Batchinschi, L. A. Pjdgurschi, L. M. Turca | ||
"... more often beta-adrenoblockers (BAB), somewhat less often – angiotensinconverting enzyme (emACE/em ..." | ||
Vol 16, No 2 (2020) | LIS-3 Acute Coronary Syndrome Registry: Changes in Clinical and Demographic Characteristics and Tactics of Prehospital and Hospital Treatment of Surviving Patients After Acute Coronary Syndrome Over a 4-Year Period | Abstract similar documents |
S. Yu. Martsevich, A. V. Zagrebelnyy, N. P. Zolotareva, N. P. Kutishenko, Yu. V. Lukina, M. L. Ginzburg, D. A. Startsev, S. V. Blagodatskikh | ||
"... of use of acetylsalicylic acid, clopidogrel, statins, beta-blockers, emACE/em inhibitors, angiotensin II ..." | ||
Vol 17, No 3 (2021) | Chronic Heart Failure in Patients with Arterial Hypertension Associated with Obstructive Sleep Apnea Syndrome: Possible Options to Pathogenetic Therapy | Abstract similar documents |
A. V. Yakovlev, S. N. Shilov, E. N. Berezikova, N. F. Yakovleva, A. T. Teplyakov, E. V. Grakova, K. V. Kopeva, I. A. Efremov | ||
"... antagonists, diuretics, emACE/em inhibitors or angiotensin receptor inhibitors or valsartan/sacubitrile. After 12 ..." | ||
1 - 100 of 258 Items | 1 2 3 > >> |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)